Fed. Circ. Warned USPTO Ruling Threatens Antibody Patents
A U.S. Patent and Trademark Office decision rejecting Xencor Inc.'s application for a patent on antibodies that can be used in autoimmune disease treatments could significantly hinder the ability to obtain...To view the full article, register now.
Already a subscriber? Click here to view full article